It is being described as Canada’s greatest contribution to the fight against COVID-19 – and it was invented right here in B.C.. Vancouver’s Tom Madden helped develop a key element… Read More
Bold Therapeutics is excited to share further information elucidating the mechanism-of-action of BOLD-100 and demonstrating its unique potential as an anticancer agent. Read more here.
At the 2022 Roth Conference in California, InMed’s CEO, Eric A. Adams, sat down with Roth Capital Analyst Scott R. Henry in a fireside chat. During their discussion, Eric talks… Read More
Vancouver, BC, Canada and New York, NY – Aspect Biosystems (“Aspect”), a biotechnology company developing bioengineered tissue therapeutics to transform how we treat disease, is pleased to announce a partnership… Read More
VANCOUVER, BC — Bold Therapeutics, a clinical-stage biopharmaceutical company, announced that will be presenting research supporting the use of BOLD-100 in combination with a wide range of anticancer therapies in the… Read More
